Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2025-07-31 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Board Meeting — INNOVA CAPTAB LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the…
Regulatory Filings
2025-07-31 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about a scheduled Board Meeting to consider and approve the unaudited financial results for the quarter ended June 30, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about Board Meetings. The document does not contain the financial results themselves but is an announcement of the upcoming meeting where such results will be considered. The document length is short (2201 characters), and it is clearly an intimation or notice rather than the financial report itself. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and not an Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-07-30 English
Monitoring Agency Report
Capital/Financing Update Classification · 95% confidence The document is a Monitoring Agency Report for the quarter ended June 30, 2025, related to the utilization of IPO proceeds by Innova Captab Limited. It references SEBI regulations specific to monitoring IPO proceeds and includes detailed financial data on the use of funds, certifications, and comments from the monitoring agency and the board. The report is comprehensive and contains substantive financial data and analysis for a quarterly period, specifically focusing on the monitoring of IPO proceeds utilization. This fits the definition of a specialized financial report related to capital utilization and monitoring, which aligns best with the category Capital/Financing Update (CAP). It is not a general quarterly financial report (IR), nor an announcement or certification only (RNS), nor an annual report (10-K).
2025-07-25 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025. It is a compliance certificate from the Registrar & Share Transfer Agent confirming no requests for dematerialization/rematerialization of shares were received during the quarter. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or substantive financial data. The document length is short (2575 characters) and it is a certification letter. According to the CERTIFICATION RULE and the nature of the document, it should be classified as a Regulatory Filing (RNS).
2025-07-07 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the publication of a newspaper advertisement about the 21st Annual General Meeting (AGM) of Innova Captab Limited. It mentions the dispatch of the notice of the AGM and the Integrated Report for FY 2024-25 via email to shareholders. The document primarily serves as a notification of the advertisement and the AGM notice dispatch, not the AGM materials themselves. It references the AGM and the Integrated Report but does not contain the report or detailed financial data. The document length is about 15,000 characters, but the content is focused on the announcement of the advertisement and notice dispatch. Therefore, according to the "Menu vs Meal" rule, this is an announcement related to the AGM, not the AGM materials themselves. Hence, the appropriate classification is AGM Information (AGM-R).
2025-07-05 English
Shareholders meeting
Regulatory Filings
2025-07-04 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.